Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Anti-Retroviral Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-Retroviral Drugsmarket, defines the market attractiveness level of Anti-Retroviral Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Anti-Retroviral Drugs industry, describes the types of Anti-Retroviral Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-Retroviral Drugs market and the development prospects and opportunities of Anti-Retroviral Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-Retroviral Drugs market in Chapter 13.
By Player:
AstraZeneca
Cardiac Science Corp
Biotelemetry
GE Healthcare
Gilead
Roche
GlaxoSmithKline
Cardionet
Cardiocom
Abbott
Bristol-Myers-Squibb
By Type:
Protease Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Integrase Inhibitors
Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors
By End-User:
Hepatitis
HIV/AIDS
Herpes
Influenza
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Anti-Retroviral Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Anti-Retroviral Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Anti-Retroviral Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Anti-Retroviral Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Anti-Retroviral Drugs Market Analysis and Outlook to 2022
-
7.1 Global Anti-Retroviral Drugs Consumption (2017-2022)
-
7.2 United States Anti-Retroviral Drugs Consumption (2017-2022)
-
7.3 Europe Anti-Retroviral Drugs Consumption (2017-2022)
-
7.4 China Anti-Retroviral Drugs Consumption (2017-2022)
-
7.5 Japan Anti-Retroviral Drugs Consumption (2017-2022)
-
7.6 India Anti-Retroviral Drugs Consumption (2017-2022)
-
7.7 South Korea Anti-Retroviral Drugs Consumption (2017-2022)
8 Region and Country-wise Anti-Retroviral Drugs Market Analysis and Outlook to 2028
-
8.1 Global Anti-Retroviral Drugs Consumption Forecast (2022-2028)
-
8.2 United States Anti-Retroviral Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Anti-Retroviral Drugs Consumption Forecast (2022-2028)
-
8.4 China Anti-Retroviral Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Anti-Retroviral Drugs Consumption Forecast (2022-2028)
-
8.6 India Anti-Retroviral Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Anti-Retroviral Drugs Consumption Forecast (2022-2028)
9 Global Anti-Retroviral Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Anti-Retroviral Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Integrase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Anti-Retroviral Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global HIV/AIDS Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Herpes Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Influenza Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Anti-Retroviral Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Anti-Retroviral Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Integrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Anti-Retroviral Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global HIV/AIDS Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Herpes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Anti-Retroviral Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Anti-Retroviral Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Anti-Retroviral Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Anti-Retroviral Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Anti-Retroviral Drugs Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Anti-Retroviral Drugs Product and Service
-
14.2 Cardiac Science Corp
-
14.2.1 Cardiac Science Corp Company Details
-
14.2.2 Cardiac Science Corp Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Cardiac Science Corp Anti-Retroviral Drugs Product and Service
-
14.3 Biotelemetry
-
14.3.1 Biotelemetry Company Details
-
14.3.2 Biotelemetry Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biotelemetry Anti-Retroviral Drugs Product and Service
-
14.4 GE Healthcare
-
14.4.1 GE Healthcare Company Details
-
14.4.2 GE Healthcare Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GE Healthcare Anti-Retroviral Drugs Product and Service
-
14.5 Gilead
-
14.5.1 Gilead Company Details
-
14.5.2 Gilead Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Gilead Anti-Retroviral Drugs Product and Service
-
14.6 Roche
-
14.6.1 Roche Company Details
-
14.6.2 Roche Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Roche Anti-Retroviral Drugs Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Anti-Retroviral Drugs Product and Service
-
14.8 Cardionet
-
14.8.1 Cardionet Company Details
-
14.8.2 Cardionet Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Cardionet Anti-Retroviral Drugs Product and Service
-
14.9 Cardiocom
-
14.9.1 Cardiocom Company Details
-
14.9.2 Cardiocom Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Cardiocom Anti-Retroviral Drugs Product and Service
-
14.10 Abbott
-
14.10.1 Abbott Company Details
-
14.10.2 Abbott Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Abbott Anti-Retroviral Drugs Product and Service
-
14.11 Bristol-Myers-Squibb
-
14.11.1 Bristol-Myers-Squibb Company Details
-
14.11.2 Bristol-Myers-Squibb Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bristol-Myers-Squibb Anti-Retroviral Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Anti-Retroviral Drugs
-
Figure Anti-Retroviral Drugs Picture
-
Table Global Anti-Retroviral Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Retroviral Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Anti-Retroviral Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Anti-Retroviral Drugs Consumption by Country (2017-2022)
-
Figure United States Anti-Retroviral Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Anti-Retroviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Anti-Retroviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Anti-Retroviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Anti-Retroviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Anti-Retroviral Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Anti-Retroviral Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Anti-Retroviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Anti-Retroviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Anti-Retroviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Anti-Retroviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Anti-Retroviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Anti-Retroviral Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Protease Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Integrase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis Consumption and Growth Rate (2017-2022)
-
Figure Global HIV/AIDS Consumption and Growth Rate (2017-2022)
-
Figure Global Herpes Consumption and Growth Rate (2017-2022)
-
Figure Global Influenza Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Protease Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Integrase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Nucleoside Analogs and Nucleoside Reverse Transcriptase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global HIV/AIDS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Herpes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Influenza Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Anti-Retroviral Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Anti-Retroviral Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Anti-Retroviral Drugs Product and Service
-
Table Cardiac Science Corp (Foundation Year, Company Profile and etc.)
-
Table Cardiac Science Corp Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardiac Science Corp Anti-Retroviral Drugs Product and Service
-
Table Biotelemetry (Foundation Year, Company Profile and etc.)
-
Table Biotelemetry Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotelemetry Anti-Retroviral Drugs Product and Service
-
Table GE Healthcare (Foundation Year, Company Profile and etc.)
-
Table GE Healthcare Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GE Healthcare Anti-Retroviral Drugs Product and Service
-
Table Gilead (Foundation Year, Company Profile and etc.)
-
Table Gilead Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gilead Anti-Retroviral Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Anti-Retroviral Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Anti-Retroviral Drugs Product and Service
-
Table Cardionet (Foundation Year, Company Profile and etc.)
-
Table Cardionet Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardionet Anti-Retroviral Drugs Product and Service
-
Table Cardiocom (Foundation Year, Company Profile and etc.)
-
Table Cardiocom Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cardiocom Anti-Retroviral Drugs Product and Service
-
Table Abbott (Foundation Year, Company Profile and etc.)
-
Table Abbott Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Anti-Retroviral Drugs Product and Service
-
Table Bristol-Myers-Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers-Squibb Anti-Retroviral Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers-Squibb Anti-Retroviral Drugs Product and Service
-
